Nanohale AG (ETR:FYB)

BRIEF

published on 07/14/2026 at 06:35, 11 days 17 hours ago

Formycon AG and OneSource Specialty Pharma Forge Biosimilars Manufacturing Partnership

Formycon AG Biosimilars Global Markets Manufacturing Partnership OneSource Pharma
PRESS RELEASE

published on 07/14/2026 at 06:30, 11 days 17 hours ago

Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma announce strategic manufacturing partnership for biosimilars, enhancing global access to high-quality, affordable biologics. Collaboration between Formycon and OneSource strengthens supply capabilities and manufacturing expertise

Manufacturing Partnership Formycon AG Biosimilars OneSource Specialty Pharma
BRIEF

published on 06/22/2026 at 09:02, 1 month 3 days ago

Formycon AG: Buy Rating Reaffirmed Amid Promising Developments

Revenue Forecast BUY Rating Formycon AG Biosimilars Keytruda
PRESS RELEASE

published on 06/22/2026 at 08:57, 1 month 3 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH issued an update on Formycon AG, maintaining a Buy recommendation and reducing the target price to €50. Recent positive developments drive optimism for Formycon's sales of Keytruda biosimilar FYB206

First Berlin Equity Research Buy Recommendation Formycon AG FYB206 Keytruda Biosimilar
BRIEF

published on 06/10/2026 at 16:27, 1 month 15 days ago

Formycon AG Holds Annual General Meeting 2026

Shareholder Approval Formycon AG Biosimilar Pipeline AGM 2026 FYB4Growth
PRESS RELEASE

published on 06/10/2026 at 16:22, 1 month 15 days ago

Formycon AG Reports Results of Annual General Meeting 2026
Formycon AG reports results of Annual General Meeting 2026, including fiscal year 2025 review, strategic priorities, and growth strategy. Shareholders approve resolutions

Annual General Meeting Formycon AG Biosimilars Shareholder Resolutions Fiscal Year Review
BRIEF

published on 05/28/2026 at 06:35, 1 month 28 days ago

Formycon Achieves Strong Revenue Growth and Operational Progress in Q1 2026

Revenue Growth Biosimilars Operational Progress Formycon FYB4Growth
PRESS RELEASE

published on 05/28/2026 at 06:30, 1 month 28 days ago

Formycon Reports Positive Operational Progress and Strong Revenue Growth in the First Quarter of 2026
Formycon reports positive operational progress and strong revenue growth in the first quarter of 2026. Achievements in biosimilar portfolio and strategic roadmap. Financial figures and guidance confirmed

Financial Results Revenue Growth Biosimilars Formycon Positive Progress
BRIEF

published on 05/21/2026 at 06:35, 2 months 4 days ago

Formycon Announces First Quarter 2026 Results Conference and Investor Conference Participation

Investor Conferences Formycon AG Financial Outlook Q1 2026 Results Biosimilars Market
PRESS RELEASE

published on 05/21/2026 at 06:30, 2 months 4 days ago

Formycon invites to conference call on the results of the first quarter of 2026 and announces participation in international investor conferences
Formycon AG invites to conference call on Q1 2026 results and announces participation in investor conferences. Key focus on biosimilars and financial outlook

Conference Call Investor Conferences Formycon AG Biosimilars Q1 2026 Results

Published on 07/25/2026 at 00:35, 23 hours 24 minutes ago

Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day ago

NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 1 hour ago

Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 1 hour ago

Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 3 hours ago

Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update

View all ACCESSWIRE

Published on 07/24/2026 at 19:06, 1 day 4 hours ago

End of Stabilisation Notice
Published on 07/24/2026 at 19:04, 1 day 4 hours ago

Stabilisation Notice
Published on 07/24/2026 at 18:44, 1 day 5 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 17:50, 1 day 6 hours ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 1 day 6 hours ago

2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.

View all EQS

Published on 07/24/2026 at 18:50, 1 day 5 hours ago

Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:11, 1 day 5 hours ago

H1 2026 liquidity contract statement for TF1
Published on 07/24/2026 at 18:06, 1 day 5 hours ago

TF1 First-Half 2026 Financial Report
Published on 07/24/2026 at 18:00, 1 day 5 hours ago

TF1 H1 2026 results - Press release
Published on 07/24/2026 at 08:00, 1 day 15 hours ago

Accor signs a definitive binding agreement on the sale of its stake in Essendi

View all LES ECHOS COMFI WIRE

News